Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q17151936> ?p ?o }
Showing triples 1 to 39 of
39
with 100 triples per page.
- Q17151936 subject Q7151811.
- Q17151936 subject Q7369063.
- Q17151936 abstract "HspE7 is an investigational therapeutic vaccine candidate being developed by Nventa Biopharmaceuticals for the treatment of precancerous and cancerous lesions caused by the human papillomavirus (HPV). HspE7 uses recombinant DNA technology to covalently fuse a heat shock protein (Hsp) to a target antigen, thereby stimulating cellular immune system responses to specific diseases. HspE7 is a patented construct consisting of the HPV Type 16 E7 protein and heat shock protein 65 (Hsp65) and is currently the only candidate using Hsp technology to target the over 20 million Americans already infected with HPV.The candidate is being developed with a Toll-like receptor 3 (TLR3) agonist adjuvant for multiple indications, including cervical intraepithelial neoplasia (also known as cervical dysplasia or CIN), genital warts, cervical cancer, and head and neck cancers.".
- Q17151936 thumbnail HspE7_Construct.gif?width=300.
- Q17151936 wikiPageWikiLink Q103537.
- Q17151936 wikiPageWikiLink Q1088163.
- Q17151936 wikiPageWikiLink Q12078.
- Q17151936 wikiPageWikiLink Q127920.
- Q17151936 wikiPageWikiLink Q1342955.
- Q17151936 wikiPageWikiLink Q134808.
- Q17151936 wikiPageWikiLink Q1483951.
- Q17151936 wikiPageWikiLink Q14866230.
- Q17151936 wikiPageWikiLink Q160105.
- Q17151936 wikiPageWikiLink Q1783924.
- Q17151936 wikiPageWikiLink Q184627.
- Q17151936 wikiPageWikiLink Q196788.
- Q17151936 wikiPageWikiLink Q204711.
- Q17151936 wikiPageWikiLink Q207609.
- Q17151936 wikiPageWikiLink Q208726.
- Q17151936 wikiPageWikiLink Q2303073.
- Q17151936 wikiPageWikiLink Q2575335.
- Q17151936 wikiPageWikiLink Q2643555.
- Q17151936 wikiPageWikiLink Q285697.
- Q17151936 wikiPageWikiLink Q3497004.
- Q17151936 wikiPageWikiLink Q389934.
- Q17151936 wikiPageWikiLink Q418939.
- Q17151936 wikiPageWikiLink Q428253.
- Q17151936 wikiPageWikiLink Q463665.
- Q17151936 wikiPageWikiLink Q484827.
- Q17151936 wikiPageWikiLink Q7070720.
- Q17151936 wikiPageWikiLink Q7151811.
- Q17151936 wikiPageWikiLink Q7369063.
- Q17151936 wikiPageWikiLink Q827023.
- Q17151936 wikiPageWikiLink Q900189.
- Q17151936 wikiPageWikiLink Q942976.
- Q17151936 wikiPageWikiLink Q967453.
- Q17151936 comment "HspE7 is an investigational therapeutic vaccine candidate being developed by Nventa Biopharmaceuticals for the treatment of precancerous and cancerous lesions caused by the human papillomavirus (HPV). HspE7 uses recombinant DNA technology to covalently fuse a heat shock protein (Hsp) to a target antigen, thereby stimulating cellular immune system responses to specific diseases.".
- Q17151936 label "HspE7".
- Q17151936 depiction HspE7_Construct.gif.